Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

2.

The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations.

Sakao S, Voelkel NF, Tatsumi K.

Eur Respir Rev. 2014 Sep;23(133):350-5. doi: 10.1183/09059180.00007913. Review.

3.

Increased S100A4 expression in the vasculature of human COPD lungs and murine model of smoke-induced emphysema.

Reimann S, Fink L, Wilhelm J, Hoffmann J, Bednorz M, Seimetz M, Dessureault I, Troesser R, Ghanim B, Klepetko W, Seeger W, Weissmann N, Kwapiszewska G.

Respir Res. 2015 Oct 20;16:127. doi: 10.1186/s12931-015-0284-5.

4.

Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema.

Demedts IK, Demoor T, Bracke KR, Joos GF, Brusselle GG.

Respir Res. 2006 Mar 30;7:53. Review.

5.

[New pathophysiological concepts in pulmonary hypertension in COPD].

Firă-Mladinescu O, Tudorache V, Mihăicuţă S, Cristescu A.

Pneumologia. 2003 Jul-Dec;52(3-4):188-92. Review. Romanian.

PMID:
18210732
6.

Pulmonary hypertension in chronic obstructive pulmonary disease.

Barberà JA, Peinado VI, Santos S.

Eur Respir J. 2003 May;21(5):892-905. Review.

7.

Pulmonary hypertension in patients with chronic obstructive pulmonary disease: recent advances in pathophysiology and management.

Hida W, Tun Y, Kikuchi Y, Okabe S, Shirato K.

Respirology. 2002 Mar;7(1):3-13. Review.

PMID:
11896895
8.

Everything prevents emphysema: are animal models of cigarette smoke-induced chronic obstructive pulmonary disease any use?

Churg A, Sin DD, Wright JL.

Am J Respir Cell Mol Biol. 2011 Dec;45(6):1111-5. doi: 10.1165/rcmb.2011-0087PS. Epub 2011 Jun 17. Review.

PMID:
21685155
9.

[Pulmonary hypertension and cor pulmonale in COPD].

Kuwahira I, Iwamoto T.

Nihon Rinsho. 2003 Dec;61(12):2138-43. Review. Japanese.

PMID:
14674323
10.

[Chronic obstructive pulmonary disease (COPD): current concepts].

Louis R.

Rev Med Liege. 2001 Oct;56(10):689-95. Review. French.

PMID:
11765579
11.

Pulmonary hypertension in COPD: pathophysiology and therapeutic targets.

Zakynthinos E, Daniil Z, Papanikolaou J, Makris D.

Curr Drug Targets. 2011 Apr;12(4):501-13. Review.

PMID:
21194405
12.

[Structural abnormalities and inflammation in COPD: a focus on small airways].

Burgel PR, Bourdin A, Pilette C, Garcia G, Chanez P, Tillie-Leblond I.

Rev Mal Respir. 2011 Jun;28(6):749-60. doi: 10.1016/j.rmr.2011.01.009. Epub 2011 May 25. Review. French.

PMID:
21742236
13.

The pathology of chronic obstructive pulmonary disease.

Hogg JC, Timens W.

Annu Rev Pathol. 2009;4:435-59. doi: 10.1146/annurev.pathol.4.110807.092145. Review.

PMID:
18954287
14.

Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice.

Seimetz M, Parajuli N, Pichl A, Veit F, Kwapiszewska G, Weisel FC, Milger K, Egemnazarov B, Turowska A, Fuchs B, Nikam S, Roth M, Sydykov A, Medebach T, Klepetko W, Jaksch P, Dumitrascu R, Garn H, Voswinckel R, Kostin S, Seeger W, Schermuly RT, Grimminger F, Ghofrani HA, Weissmann N.

Cell. 2011 Oct 14;147(2):293-305. doi: 10.1016/j.cell.2011.08.035.

15.

Animal models of cigarette smoke-induced chronic obstructive pulmonary disease.

Wright JL, Churg A.

Expert Rev Respir Med. 2010 Dec;4(6):723-34. doi: 10.1586/ers.10.68.

PMID:
21128748
16.

Pulmonary vascular abnormalities in chronic obstructive pulmonary disease undergoing lung transplant.

Peinado VI, Gómez FP, Barberà JA, Roman A, Angels Montero M, Ramírez J, Roca J, Rodriguez-Roisin R.

J Heart Lung Transplant. 2013 Dec;32(12):1262-9. doi: 10.1016/j.healun.2013.09.007.

PMID:
24263025
17.

Pulmonary hypertension in COPD: old and new concepts.

Barberà JA, Peinado VI, Santos S.

Monaldi Arch Chest Dis. 2000 Dec;55(6):445-9. Review.

PMID:
11272628
18.
19.

Vasoactive mediators and pulmonary hypertension after cigarette smoke exposure in the guinea pig.

Wright JL, Tai H, Churg A.

J Appl Physiol (1985). 2006 Feb;100(2):672-8. Epub 2005 Oct 6.

20.

Supplemental Content

Support Center